1tsu: Difference between revisions

Revision as of 16:17, 21 February 2008

CRYSTAL STRUCTURE OF DECAMER NCP1 SUBSTRATE PEPTIDE IN COMPLEX WITH WILD-TYPE D25N HIV-1 PROTEASE VARIANT

OverviewOverview

Maturation of human immunodeficiency virus (HIV) depends on the processing of Gag and Pol polyproteins by the viral protease, making this enzyme a prime target for anti-HIV therapy. Among the protease substrates, the nucleocapsid-p1 (NC-p1) sequence is the least homologous, and its cleavage is the rate-determining step in viral maturation. In the other substrates of HIV-1 protease, P1 is usually either a hydrophobic or an aromatic residue, and P2 is usually a branched residue. NC-p1, however, contains Asn at P1 and Ala at P2. In response to the V82A drug-resistant protease mutation, the P2 alanine of NC-p1 mutates to valine (AP2V). To provide a structural rationale for HIV-1 protease binding to the NC-p1 cleavage site, we solved the crystal structures of inactive (D25N) WT and V82A HIV-1 proteases in complex with their respective WT and AP2V mutant NC-p1 substrates. Overall, the WT NC-p1 peptide binds HIV-1 protease less optimally than the AP2V mutant, as indicated by the presence of fewer hydrogen bonds and fewer van der Waals contacts. AlaP2 does not fill the P2 pocket completely; PheP1' makes van der Waals interactions with Val82 that are lost with the V82A protease mutation. This loss is compensated by the AP2V mutation, which reorients the peptide to a conformation more similar to that observed in other substrate-protease complexes. Thus, the mutant substrate not only binds the mutant protease more optimally but also reveals the interdependency between the P1' and P2 substrate sites. This structural interdependency results from coevolution of the substrate with the viral protease.

About this StructureAbout this Structure

1TSU is a Protein complex structure of sequences from [1]. Active as HIV-1 retropepsin, with EC number 3.4.23.16 Full crystallographic information is available from OCA.

ReferenceReference

Structural basis for coevolution of a human immunodeficiency virus type 1 nucleocapsid-p1 cleavage site with a V82A drug-resistant mutation in viral protease., Prabu-Jeyabalan M, Nalivaika EA, King NM, Schiffer CA, J Virol. 2004 Nov;78(22):12446-54. PMID:15507631

Page seeded by OCA on Thu Feb 21 15:16:56 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:1tsu.gif|left|200px]]<br />
+[[Image:1tsu.gif|left|200px]]<br /><applet load="1tsu" size="350" color="white" frame="true" align="right" spinBox="true"
-<applet load="1tsu" size="450" color="white" frame="true" align="right" spinBox="true"
 caption="1tsu, resolution 2.10&Aring;" />
 '''CRYSTAL STRUCTURE OF DECAMER NCP1 SUBSTRATE PEPTIDE IN COMPLEX WITH WILD-TYPE D25N HIV-1 PROTEASE VARIANT'''<br />
 ==Overview==
-Maturation of human immunodeficiency virus (HIV) depends on the processing, of Gag and Pol polyproteins by the viral protease, making this enzyme a, prime target for anti-HIV therapy. Among the protease substrates, the, nucleocapsid-p1 (NC-p1) sequence is the least homologous, and its cleavage, is the rate-determining step in viral maturation. In the other substrates, of HIV-1 protease, P1 is usually either a hydrophobic or an aromatic, residue, and P2 is usually a branched residue. NC-p1, however, contains, Asn at P1 and Ala at P2. In response to the V82A drug-resistant protease, mutation, the P2 alanine of NC-p1 mutates to valine (AP2V). To provide a, structural rationale for HIV-1 protease binding to the NC-p1 cleavage, site, we solved the crystal structures of inactive (D25N) WT and V82A, HIV-1 proteases in complex with their respective WT and AP2V mutant NC-p1, substrates. Overall, the WT NC-p1 peptide binds HIV-1 protease less, optimally than the AP2V mutant, as indicated by the presence of fewer, hydrogen bonds and fewer van der Waals contacts. AlaP2 does not fill the, P2 pocket completely; PheP1' makes van der Waals interactions with Val82, that are lost with the V82A protease mutation. This loss is compensated by, the AP2V mutation, which reorients the peptide to a conformation more, similar to that observed in other substrate-protease complexes. Thus, the, mutant substrate not only binds the mutant protease more optimally but, also reveals the interdependency between the P1' and P2 substrate sites., This structural interdependency results from coevolution of the substrate, with the viral protease.
+Maturation of human immunodeficiency virus (HIV) depends on the processing of Gag and Pol polyproteins by the viral protease, making this enzyme a prime target for anti-HIV therapy. Among the protease substrates, the nucleocapsid-p1 (NC-p1) sequence is the least homologous, and its cleavage is the rate-determining step in viral maturation. In the other substrates of HIV-1 protease, P1 is usually either a hydrophobic or an aromatic residue, and P2 is usually a branched residue. NC-p1, however, contains Asn at P1 and Ala at P2. In response to the V82A drug-resistant protease mutation, the P2 alanine of NC-p1 mutates to valine (AP2V). To provide a structural rationale for HIV-1 protease binding to the NC-p1 cleavage site, we solved the crystal structures of inactive (D25N) WT and V82A HIV-1 proteases in complex with their respective WT and AP2V mutant NC-p1 substrates. Overall, the WT NC-p1 peptide binds HIV-1 protease less optimally than the AP2V mutant, as indicated by the presence of fewer hydrogen bonds and fewer van der Waals contacts. AlaP2 does not fill the P2 pocket completely; PheP1' makes van der Waals interactions with Val82 that are lost with the V82A protease mutation. This loss is compensated by the AP2V mutation, which reorients the peptide to a conformation more similar to that observed in other substrate-protease complexes. Thus, the mutant substrate not only binds the mutant protease more optimally but also reveals the interdependency between the P1' and P2 substrate sites. This structural interdependency results from coevolution of the substrate with the viral protease.
 ==About this Structure==
-TSU is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ]. Active as [http://en.wikipedia.org/wiki/HIV-1_retropepsin HIV-1 retropepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.16 3.4.23.16] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1TSU OCA].
+TSU is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ]. Active as [http://en.wikipedia.org/wiki/HIV-1_retropepsin HIV-1 retropepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.16 3.4.23.16] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1TSU OCA].
 ==Reference==
@@ Line 14: / Line 13: @@
 [[Category: HIV-1 retropepsin]]
 [[Category: Protein complex]]
-[[Category: King, N.M.]]
+[[Category: King, N M.]]
-[[Category: Nalivaika, E.A.]]
+[[Category: Nalivaika, E A.]]
 [[Category: Prabu-Jeyabalan, M.]]
-[[Category: Schiffer, C.A.]]
+[[Category: Schiffer, C A.]]
 [[Category: co-evolution]]
 [[Category: hiv-1 protease]]
@@ Line 23: / Line 22: @@
 [[Category: substrate recognition]]
-''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Thu Nov  8 14:31:46 2007''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:16:56 2008''